SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

LENZ Licenses VIZZ

LENZ Therapeutics and Arrotex Pharmaceuticals announce exclusive license and commercialization agreement for VIZZ in Australia and New Zealand

LENZ

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.